ISN Journal summaries on IgA nephropathy and conservative kidney management
Kidney International® Treatment of patients with IgA nephropathy: a call for a new paradigm Current treatments for IgA nephropathy (IgAN), including supportive care and corticosteroids, have limited success and significant side effects. Advances in understanding IgAN’s pathogenesis have led to new targeted therapies and a proposed dual approach: targeting IgAN-specific mechanisms (e.g., pathogenic IgA production) and managing...